Ovarian cancer experts are being called to testify in a St. Louis talcum powder cancer lawsuit to explain the findings of their research concerning the link between talcum powder and ovarian cancer.

A national talcum powder lawsuit is currently underway in St. Louis, which lead to medical experts and ovarian cancer specialists, Dr. John Godleski and Dr. Daniel Cramer, have been summoned to the court to give their depositions. This St. Louis talcum powder lawsuit is currently one of the largest underway in the nation.

The plaintiff party reportedly consists of over 50 women, who developed ovarian cancer allegedly as a result of using Johnson & Johnson’s talcum powder for feminine hygiene. Other defendants named in the lawsuit include Imerys Talc America and Walgreens.

Plaintiffs involved in this case include a woman who suffered talcum powder ovarian cancer, while another family filed on behalf of their deceased relative.

Both sets of plaintiffs, as well as the others in the case, claim that they were unaware of the alleged connection between ovarian cancer and talcum powder. Furthermore, the women claim that they never would have used the talcum powder, if they had known the risks.

Overview of Talcum Powder Cancer Allegations

While talcum powder has been a staple hygiene product for generations, concern has recently been raised regarding its alleged link with ovarian cancer. Women commonly use talcum powder to treat yeast infections and wet skin, but when applied to their genital area, the talc particles enter their bodies.

Once the particles enter the bloodstream and then fallopian tubes, the particles can remain sedentary up to eight years. While the threat is not immediate, the talc particles eventually fester and cause cancer cells to overtake the ovaries.

The doctors being summoned to testify in the St. Louis baby powder cancer lawsuit, both concluded that talcum powder can potentially increase the woman’s chances of ovarian cancer when used for feminine hygiene purposes.

In fact Dr. Cramer and Dr. Godleski published a study titled, “Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc“, in the August 2007 issue of Journal of Obstetrics and Gynecology.

Dr. Cramer further cements his stance on the matter on his Harvard Medical School physician profile page, stating that “cosmetic talc powder use” is one of “three events which increase [the] risk for ovarian cancer”.

Dr. Cramer has been called forward before, being involved in the first talcum powder cancer lawsuit, which ended favorably for plaintiff Deane B. in 2013. The St. Louis talcum powder cancer lawsuit is set to go to trial on Feb. 1, 2016.

This Talcum Powder Cancer Lawsuit is Tiffany Hogans et al v Johnson and Johnson et al, Case No. 1422-Cc09012-01, in the City of St. Louis Circuit Court.